Skip to main content

Genetic Technologies, PreventionGenetics Settle Patent Infringement Lawsuit

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled a lawsuit it filed against PreventionGenetics late last year claiming patent infringement.

The two parties have also reached a licensing agreement, and GTG's lawsuit will be dismissed as a result. Terms of the settlement were not disclosed.

GTG sued Marshfield, Wis.-based PreventionGenetics in November alleging it infringed US Patent No. 5,612,179, which covers GTG's non-DNA coding technology. The patent is at the center of numerous patent infringement lawsuits filed by the Australian firm.

Earlier this month, the US Patent and Trademark Office granted a request from Merial for a second ex parte re-examination of the patent. In December, GTG settled with Roche 454 Life Sciences over the '179 patent. The two also reached a licensing agreement.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.